Finally, it is possible that both a reduction, which is the case in our mouse model—or an excess, which occurs in AD and other tauopathies—in δTau lead to synaptic dysfunction, memory impairments and Tau pathology. This evidence concerns the gene MAPT and Alzheimer disease.